Benzo[d]imidazole–Naphthalen-Arylmethanone Regioisomers as CB1 Ligands: Evaluation of Agonism via an Indirect Cytotoxicity-Based Approach
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26209986 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Analia Young Hwa Cho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Organic Chemistry and Physical Chemistry Department, Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, Olivos 1007, Santiago 782…. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Naphthalenes, Imidazoles, Antineoplastic Agents. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, Vicerrectoría de Investigación y Desarrollo (VID) de la Universidad de Chile, FONDECYT projects: Fondecyt Iniciación.
Abstract (Originalsprache)
CB1 agonist compounds may be potential drug candidates for the treatment of gliomas, as they have been shown to inhibit tumor cell proliferation, induce apoptosis, and reduce angiogenesis in various preclinical models. Their ability to modulate the endocannabinoid system suggests a promising therapeutic approach for targeting glioma growth and progression. Herein, we report the design, synthesis, biological studies, and bioinformatics assays of novel benzo[d]imidazole–naphthalen-arylmethanone regioisomers with affinity for the CB1 receptor, as well as propose an indirect methodology to evaluate their presumed CB1 agonist activity. Compounds that showed a propensity for binding to the CB1 receptor were regioisomers 4d, 5b, 5e, 5f, and 5f′. Likewise, derivatives that displaced more than 50% of the radioligand [3H]CP-55940 at the CB1 receptor were subjected to in vitro viability experiments. Compounds 4d, 5b, 5e, and 5f′ showed toxicity against U87MG cells (malignant glioma) in a considerable percentage. Notably, compound 5f′ showed CB1 affinity, with a Ki of 2.12 µM, and was selectively toxic to U87MG cells, which highly express the CB1 receptor, while exhibiting no toxicity toward the healthy HEK293 cell line, which expresses both cannabinoid receptors at negligible levels. Docking studies at the CB1 orthosteric site indicate that 5f′ forms π-π interactions, a T-shaped interaction, and hydrogen bonding through the oxygen atom of the furan ring. Biologically, our experimental indirect model-based on a simple viability assay is supported by well-established evidence that activation of CB1 and CB2 receptors by agonists induces cell death and inhibits tumor cell growth. Structurally, we conclude that the presence of a furan ring at the 2-position of the benzo[d]imidazole core is beneficial for the development of new ligands with potential CB1 agonist activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Organic Chemistry and Physical Chemistry Department, Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, Olivos 1007, Santiago 7820436, Chile.
- Centro de Investigación en Ingeniería de Materiales, Universidad Central de Chile, Santiago 8330507, Chile.
- Carrera de Química y Farmacia, Facultad de Ciencias de la Vida, Universidad Viña del Mar, Viña del Mar 2520000, Chile.
- Pharmacy Department, School of Pharmacy, Faculty of Chemistry and Pharmacy, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Santiago 7820436, Chile.
- Instituto de Química, Facultad de Ciencias, Universidad de Valparaíso, Av. Gran Bretaña 1111, Valparaíso 2360102, Chile.
- Centro de Investigación, Desarrollo e Innovación de Productos Bioactivos (CInBIO), Universidad de Valparaíso, Av. Gran Bretaña 1111, Valparaíso 2360102, Chile.
ORCID-Profile: Renato Burgos Ravanal, Marco Mellado, Marcos Lorca, Jaime Mella, Germán Günther Sapunar
Förderung
- Agencia Nacional de Investigación y Desarrollo
- Vicerrectoría de Investigación y Desarrollo (VID) de la Universidad de Chile
- FONDECYT projects: Fondecyt Iniciación
- Fondecyt Regular
- ANID scholarships
Zitieren
APA
Hwa Cho, A. Y., Burgos Ravanal, R., Zuñiga Salazar, V., Mellado, M., Lorca, M., Pessoa-Mahana, D., Mella, J., Günther Sapunar, G., & Romero-Parra, J. (2025). Benzo[d]imidazole–Naphthalen-Arylmethanone Regioisomers as CB1 Ligands: Evaluation of Agonism via an Indirect Cytotoxicity-Based Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209986
Vancouver
Hwa Cho AY, Burgos Ravanal R, Zuñiga Salazar V, Mellado M, Lorca M, Pessoa-Mahana D, et al. Benzo[d]imidazole–Naphthalen-Arylmethanone Regioisomers as CB1 Ligands: Evaluation of Agonism via an Indirect Cytotoxicity-Based Approach. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209986
BibTeX
@article{HwaCho2025,
author = {Hwa Cho, Analia Young and Burgos Ravanal, Renato and Zuñiga Salazar, Valeria and Mellado, Marco and Lorca, Marcos and Pessoa-Mahana, David and Mella, Jaime and Günther Sapunar, Germán and Romero-Parra, Javier},
title = {Benzo[d]imidazole–Naphthalen-Arylmethanone Regioisomers as CB1 Ligands: Evaluation of Agonism via an Indirect Cytotoxicity-Based Approach},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26209986}
}
EUVIMED